Divis Laboratories (India) Performance
| DIVISLAB | 6,152 123.50 2.05% |
The firm shows a Beta (market volatility) of 0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, Divis Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Divis Laboratories is expected to be smaller as well. At this point, Divis Laboratories has a negative expected return of -0.12%. Please make sure to confirm Divis Laboratories' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Divis Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Divis Laboratories Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Forward Dividend Yield 0.0049 | Payout Ratio 0.3448 | Last Split Factor 2:1 | Forward Dividend Rate 30 | Ex Dividend Date 2025-07-25 |
1 | Divis Laboratories Ltd up for third consecutive session - Business Standard | 06/11/2025 |
2 | Divis Laboratories Limiteds Stock On An Uptrend Could Fundamentals Be Driving The Momentum - simplywall.st | 06/19/2025 |
3 | Divis Labs Share Price Live Updates Divis Labs shows promising returns - The Economic Times | 07/02/2025 |
4 | Breakout Stocks How to trade Jaiprakash Power Ventures, JM Financial Divis Laboratories that hit 52-week high - The Economic Times | 07/08/2025 |
5 | Heres What Analysts Are Forecasting For Divis Laboratories Limited After Its Yearly Results - simplywall.st | 07/16/2025 |
6 | Divis Laboratories Limited Stock Goes Ex-Dividend In Just Three Days - simplywall.st | 07/21/2025 |
7 | Divis Laboratories Q1 Results Stock falls after profit, margins miss estimates - CNBC TV18 | 08/05/2025 |
8 | Divis Laboratories Faces Continued Stock Decline Amid Broader Market Challenges - MarketsMojo | 08/08/2025 |
9 | Divis Laboratories Releases Q1 FY2026 Earnings Call Transcript - MSN | 08/13/2025 |
10 | Divis Laboratories shares surge 2.07 percent amid high volume - Moneycontrol | 08/22/2025 |
| Begin Period Cash Flow | 3.7 B | |
| Total Cashflows From Investing Activities | -11 B |
Divis |
Divis Laboratories Relative Risk vs. Return Landscape
If you would invest 670,646 in Divis Laboratories Limited on May 26, 2025 and sell it today you would lose (55,496) from holding Divis Laboratories Limited or give up 8.28% of portfolio value over 90 days. Divis Laboratories Limited is generating negative expected returns and assumes 1.2648% volatility on return distribution over the 90 days horizon. Simply put, 11% of stocks are less volatile than Divis, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Divis Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Divis Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Divis Laboratories Limited, and traders can use it to determine the average amount a Divis Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0987
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DIVISLAB |
Estimated Market Risk
| 1.26 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Divis Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Divis Laboratories by adding Divis Laboratories to a well-diversified portfolio.
Divis Laboratories Fundamentals Growth
Divis Stock prices reflect investors' perceptions of the future prospects and financial health of Divis Laboratories, and Divis Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Divis Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0992 | ||||
| Profit Margin | 0.24 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.6 T | ||||
| Shares Outstanding | 265.47 M | ||||
| Price To Book | 10.91 X | ||||
| Price To Sales | 16.92 X | ||||
| Revenue | 93.58 B | ||||
| Gross Profit | 58.24 B | ||||
| EBITDA | 33.21 B | ||||
| Net Income | 21.91 B | ||||
| Cash And Equivalents | 3.94 B | ||||
| Total Debt | 40 M | ||||
| Book Value Per Share | 563.87 X | ||||
| Cash Flow From Operations | 19.46 B | ||||
| Earnings Per Share | 86.74 X | ||||
| Total Asset | 169.47 B | ||||
| Retained Earnings | 134 B | ||||
About Divis Laboratories Performance
By analyzing Divis Laboratories' fundamental ratios, stakeholders can gain valuable insights into Divis Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Divis Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Divis Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Divis Laboratories is entity of India. It is traded as Stock on NSE exchange.Things to note about Divis Laboratories performance evaluation
Checking the ongoing alerts about Divis Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Divis Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Divis Laboratories generated a negative expected return over the last 90 days | |
| About 52.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Divis Laboratories shares surge 2.07 percent amid high volume - Moneycontrol |
- Analyzing Divis Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Divis Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Divis Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Divis Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Divis Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Divis Laboratories' stock. These opinions can provide insight into Divis Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Divis Stock analysis
When running Divis Laboratories' price analysis, check to measure Divis Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Divis Laboratories is operating at the current time. Most of Divis Laboratories' value examination focuses on studying past and present price action to predict the probability of Divis Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Divis Laboratories' price. Additionally, you may evaluate how the addition of Divis Laboratories to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |